Daewoong Co., Ltd. (KRX:003090)

Market Cap	667.97B -33.2%
Revenue (ttm)	2.12T +4.6%
Net Income	179.40B +119.2%
EPS	4,328.21 +116.1%
Shares Out	42.04M
PE Ratio	3.67
Forward PE	n/a
Dividend	200.00 (1.26%)
Ex-Dividend Date	Dec 29, 2025

Volume	58,654
Open	15,870
Previous Close	15,810
Day's Range	15,680 - 15,950
52-Week Range	15,410 - 30,600
Beta	0.28
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Daewoong

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, So...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 404
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 003090

Financial Performance

In 2025, Daewoong's revenue was 2.07 trillion, an increase of 6.79% compared to the previous year's 1.94 trillion. Earnings were 175.06 billion, an increase of 202.43%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 17, 2026

Data Sources Report a data error